Chen Hang, Li Li, Fang Jin
Department of Cell Biology, Key Labaratory of Cell Biology, Ministry of Public Health, and Key Labaratory of Medical Cell Biology, Ministry of Education, China Medical University, Shenyang 110001, China.
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 2012 Apr;28(4):400-3.
To construct and express the recombinant ND-1-scFv/SEA, a fusion protein of superantigen (staphylococcal enterotoxinA, SEA) and single-chain variable fragment of monoclonal antibody ND-1 against human clolorectal carcinoma, and to enhance the targeted killing effect of SEA.
The expression of the fusion protein was induced in E.coli M15 by IPTG. Ni-NTA resin affinity chromatography was used to separate and purify the expressed product. The specific binding activity of the purified ND-1-scFv/SEA protein was examined by indirect immunofluorescence assay and the targeted-cytotoxicity was determined using MTT assay.
The expressing vector of fusion gene ND-1scFv/SEA was constructed successfully. ND-1-scFv/SEA protein retained a high binding affinity to antigen-positive human colorectal cancer cell CCL-187 and had a stronger capability to activate PBMC and kill the target cells compared to SEA alone, with a killing rate of 91% at 4 μg/mL.
ND-1-scFv/SEA fusion protein could specifically target colorectal cancer cell, enhance the activity of kill tumor cell and has potential applications in the targeted therapy of colorectal cancer.
构建并表达超抗原(葡萄球菌肠毒素A,SEA)与人结肠癌单克隆抗体ND-1单链可变片段的融合蛋白重组ND-1-scFv/SEA,增强SEA的靶向杀伤作用。
用异丙基-β-D-硫代半乳糖苷(IPTG)在大肠杆菌M15中诱导融合蛋白表达。采用镍-亚氨基二乙酸(Ni-NTA)树脂亲和层析法分离纯化表达产物。通过间接免疫荧光法检测纯化的ND-1-scFv/SEA蛋白的特异性结合活性,并用MTT法测定其靶向细胞毒性。
成功构建融合基因ND-1scFv/SEA的表达载体。ND-1-scFv/SEA蛋白与抗原阳性的人结肠癌细胞CCL-187保持高结合亲和力,与单独的SEA相比,具有更强的激活外周血单个核细胞(PBMC)和杀伤靶细胞的能力,在4μg/mL时杀伤率为91%。
ND-1-scFv/SEA融合蛋白可特异性靶向结肠癌细胞,增强杀伤肿瘤细胞的活性,在结肠癌的靶向治疗中具有潜在应用价值。